Download Unicorn Signals App

By EquityPandit

EquityPandit

EquityPandit
MARKETS

OPEC+ to Increase Production by 5 Lac Barrels from January

The OPEC+ group, which includes the Organization of the Petroleum Exporting Countries (OPEC), Russia, and other allies on late Thursday has decided to increase the crude oil production by 500,000 barrels per day from January.
Starting next month, the leading oil producers will be increasing the production of crude oil which will result in a reduced production cut level of 7.2 million barrels per day (mb/d) from the current production levels of 7.7 mb/d. In late Thursday meeting, the decision was made to gradually return back to the production levels of 2 mb/d to the global market.
“In light of the current oil market fundamentals and the outlook for 2021, the Meeting agreed to reconfirm the existing commitment under the DoC (Declaration of Cooperation) decision from 12 April 2020, then amended in June and September 2020, to gradually return 2 mb/d, given consideration to market conditions,” said OPEC in a late-night statement after the 12th OPEC and Non-OPEC Ministerial Meeting.
The OPEC+ decision is expected to help the world’s third-largest oil importer India. It also holds significance for India, as OPEC accounts for around 40 per cent of global production, of which India imports 83 per cent of crude oil. The low international crude oil price regime has also helped India to fill up its strategic crude oil reserves at an average price of $19 per barrel which saved $685.11 million.
The cost of the India’s crude oil imports, which comprises of Oman, Dubai and Brent crude was averaged at $56.43 per barrel in FY18, $69.88 in FY19 and $69.88 per barrel in FY 20. Due to the Covid-19 pandemic, the crude oil prices fell to $19.90 per barrel in April, $30.60 in May, $40.63 in June, $43.35 in July, $44.19 in August and $41.35 a barrel in the Month of September respectively, according to data from the Petroleum Planning and Analysis Cell.

Get Daily Prediction & Stocks Tips On Your Mobile


I would like to receive communication from EquityPandit via sms, email, whatsapp, Google RCS for offers, updates etc.
MARKETS

Stocks in Focus: Tata Motors, AstraZeneca Pharma India, Godrej Properties, and Others

Ali Waghbakriwala

The GIFT Nifty futures, which is an early indicator of the Nifty50 index, was trading 3.60% lower by 821 points at 22,138, indicating that the domestic benchmark indices are likely to make a negative start on Monday.

On Friday, 4 April, Domestic benchmark indices S&P BSE Sensex slumped by 931 points or 1.22% and settled at 75,365 while the Nifty50 traded 1.49% lower by 346 points, settling at 22,904.

Here are some stocks that are likely to remain in focus on 7 April.

Tata Motors: The company has decided to put a temporary halt on shipments to the US amid the 25% tariffs imposed on all foreign-made vehicles. 

AstraZeneca Pharma India: The company has announced securing approval from the Central Drugs Standard Control Organization to import Osimertinib tablets 40 mg & 80 mg (TAGRISSO). The Osimertinib tablets are used to treat non-small cell lung cancer in patients who have certain types of abnormal EGFR genes. 

Godrej Properties: The company has announced an agreement to develop a prime land parcel in Versova, Mumbai. The project has an estimated development potential of 4.4 lakh square feet of saleable area and has a revenue potential of Rs 1,350 crore. 

ITC: The company has announced acquiring an additional 2.62 lakh shares of Ample Foods for a total consideration of Rs 131 crore, taking its total stake in the company to 43.75%. 

Oil Companies: The shares of oil companies such as Reliance Industries, Oil India, Hindustan Oil Exploration, ONGC, and many more will be in focus today as global oil prices fall. 

Force Motors: The company announced selling 3,606 units of Small Commercial Vehicles, Utility Vehicles, Light Commercial Vehicles, and Sports Utility Vehicles in the Indian market in March 2025, highlighting an 11.02% year-on-year increase from the number reported in March 2024.

IT, Metals, Pharma Shares: The shares of information technology (IT), metals, and pharmaceuticals will remain in focus over the growing tensions over a global trade war after US President Donald Trump imposed tariffs.

The future of investing is here!
Unicorn Signals leverages advanced AI technology to provide you with powerful market predictions and actionable stock scans. Download the app todayand 10x your trading & investing journey!

 

MARKETS

Stocks Under F&O Ban: Birlasoft and Others

Ali Waghbakriwala

Under the futures and options (F&O) segment, two stocks were banned from trade on Monday, 7 April, by the National Stock Exchange (NSE). The securities banned for the F&O trade are Hindustan Copper and Birlasoft. 

Derivative contracts of these stocks were banned as the open market interest for these securities has crossed 95% of the market-wide position limit (MWPL) set by the exchanges. The MWPL is the maximum number of contracts that can be opened at any particular time.

Birlasoft and Hindustan Copper were added to the list on Monday as the open interest of their F&O contracts reached 100.8% and 115.1%, respectively.

The ban will be lifted once the position falls below 80%. Traders will get penalised for buying or selling these securities. They will be available for trading in the cash market. 

The National Stock Exchange updates the list of securities on the F&O ban list daily. This list serves as a guide for traders and investors in the market. Traders who trade in indices do not encounter a situation of security ban.

Feeling overwhelmed by the markets? Let Unicorn Signals be your guide. Our user-friendly app simplifies complex data and provides actionable trading signals. Download the app today and trade with confidence!

MARKETS

Mazagon Dock Shares Slump 7% on Government’s OFS 

Ali Waghbakriwala

Shares of Mazagon Dock Shipbuilders Ltd dropped more than 6% on Friday, 4 April, following the government’s announcement of an offer to sell a 4.83% stake in the state-run defence company. 

According to a stock market announcement, the Indian government would sell up to 11.39 million equity shares, or 2.83% of its holding, to non-retail investors on 4 April and to employees and retail investors on 7 April. By exercising the oversubscription option, the state-run firm can sell an extra 8.06 million shares, or 2% of the total, increasing the stake sale to 4.83%. 

At the end of the December quarter, the government-owned 84.83% of the company, according to BSE figures. 

Furthermore, 50,000 equity shares, or 0.26%stake, may be offered to eligible personnel in accordance with the terms and conditions outlined in the OFS guidelines, subject to permission from the appropriate government, the defence business stated. The offer-for-sale floor price is Rs 2,525 per share, representing a 7.7% decrease from Thursday’s closing price. 

Mazagon Dock’s stock dropped as high as 7.14% to Rs 2,542 per share, the most intraday loss since 18 February this year. 

In the previous fiscal year, Mazagon Dock was the best-performing firm, increasing by an incredible 189.2%, while the Nifty50 had a 5.7% gain. 

The company’s primary activity is building and repairing ships, submarines, and other types of watercraft for its customers. It also manufactures related engineering products.

Mazagon Dock’s consolidated net profit for the third quarter (Q3) of the fiscal year 2024-25 (FY25) increased by 30% to Rs 768.22 crore from Rs 591.54 crore in the same period the previous year.  

At 1:52 pm, the shares of Mazagon Dock were trading 6.74% lower at Rs 2,553.15 on NSE.

Ask the analyst & get instant answer about Mazagon Dock Shipbuilders Ltd.

Tired of guessing stocks to trade in daily?
Unicorn Signals empowers you with powerful tools like daily stock scans for Intraday, Swing & Investing, Market Predictions and much more. Download the Unicorn Signals app today and take control of your investments!

MARKETS

Pharma Stocks Crash on Trump’s Tariffs Remark 

Ali Waghbakriwala

It won’t be over until it is.  According to US President Donald Trump, his administration is considering potential pharmaceutical levies. “The pharma is going to be starting to come in at, I think, a level that you haven’t really seen before,” President Trump said, speaking to reporters aboard Air Force One.

Following this update at 11:15 a.m., pharmaceutical stocks fell precipitously, with the Nifty Pharma index being the biggest sectoral loser. Companies like IPCA Labs, Lupin, and Aurobindo Pharma saw a more than 6% decline, while the index fell more than 4.5%

Trump added, “We are looking at pharma as a separate category — we will be announcing that sometime in the near-future, not in the distant future.”

Prior to this, White House Press Secretary Karoline Leavitt, who has been with President Donald Trump since 20 January 2025, made a suggestion about bringing pharmaceutical production back to the United States. “We have outsourced our critical supplies chains in our countries. Do we want out life saving drugs and medicine and chips to be made in China or here in the United States of America? This is a common sense policy,” said Leavitt.

Domestic pharmaceutical players breathed a sigh of relief in trade on 3 April, while the other sectors faced significant selling pressure after the White House excluded pharmaceuticals from the reciprocal tariffs imposed by US President Donald Trump.

You Might Be Interested In

Trump revealed his tariff plan for several US trading partners on 2 April, often known as “Liberation Day,” which included a “discounted” broad-based charge of 26% on India. This amounts to half of the 52% claimed by India against the United States, which includes currency manipulation and trade barriers.

On ‘Liberation Day,’ which took place on 2 April, Trump unveiled his tariff proposal for a number of US trading partners, which included a “discounted” broad-based levy of 26% on India. This represents half of India’s 52% accusation against the United States, which includes trade barriers and currency manipulation.

According to a White House fact sheet, all pharmaceutical imports to the United States were protected from reciprocal duties. “Some goods will not be subject to the Reciprocal Tariff. These include copper, pharmaceuticals, semiconductors, and lumber articles,” said the document.

India’s pharmaceutical exports to the United States were primarily generic formulations, making drug access more expensive for American residents. As a result, they indicated that taxes on this sector were unlikely. However, with this update, pharmaceutical stocks may face significant levies.

Discover the next big investment! Unicorn Signals’ IPO screener helps you identify promising initial public offerings. Download Unicorn Signals and get ahead of the curve! Sign Up Now & Find Your Next IPO Gem!

MARKETS

Nuvoco Vistas Secures Approval from NCLT to Acquire Vadraj Cement; Shares Gain 

Ali Waghbakriwala

Shares of Nuvoco Vistas Corporation Ltd were trading in the green and 1% higher on 4 April after the company announced receiving approval from the Mumbai Bench of the National Company Law Tribunal (NCLT) for its resolution plan to purchase Vadraj Cement for Rs 1,800 crore under the Insolvency and Bankruptcy Code, making it the fifth largest cement group in India.

The deal will be completed via Nuvoco’s wholly-owned subsidiary, Vanya Corporation, which will eventually merge with VCL. After the merger, the business will wholly own VCL as a subsidiary. Nuvoco Vistas is a cement and other building supply firm owned by the Nirma Group.

The company received a letter in January 2025 stating that it intended to buy Gujarat-based Vadraj Cement (VCL) under insolvency proceedings. Prior to the acquisition, Nuvoco had said it planned to invest Rs 1800 crore, with additional investments to come.

The approval order, dated 1 April 2025, was published on the NCLT website on 3 April 2025.

After the acquisition, Nuvoco will rank as the fifth-largest cement company with a combined capacity of roughly 31 MMTPA; by Q3FY27, cement capacity will reach 31 MTPA, and clinker capacity will reach 17 MTPA.  

This acquisition will put Nuvoco Vistas in third place in Gujarat and Maharashtra in terms of capacity and expand its footprint in Western India.

Nuvoco has described the acquisition as a “valuable buy” with substantial growth potential at a very competitive price of roughly $60 per tonne, which is lower than the recent high acquisition costs seen in the market. “By acquiring Vadraj Cement, the Company is poised to reach 31 million tonnes per annum (MPTA) cement capacity by Q3FY27,” Nuvoco had said in January 2025.

Nuvoco plans to invest an additional Rs 900–1,200 crore in Vadraj over the next 18 to 24 months. Originally established as Lafarge India in 1999, the company rebranded itself as Nuvoco Vistas after being purchased by the Nirma Group in 2016.

However, at 1:06 pm, the shares of Nuvoco Vistas were trading 1.71% lower at Rs 313.60 on NSE.

Wondering About Nuvoco Vistas Corporation Ltd? The Analyst Has Answers.

The future of investing is here!
Unicorn Signals leverages advanced AI technology to provide you with powerful market predictions and actionable stock scans. Download the app todayand 10x your trading & investing journey!

@2025 - www.equitypandit.com. All Right Reserved.
Latest
IPO
Weekly
Outlook

Stock
Market
Prediction